Oncology Biomarkers Global Market to 2028: Increased Availability and Ease of Biomarker Testing Fuels the Sector
04 juil. 2023 05h13 HE
|
Research and Markets
Dublin, July 04, 2023 (GLOBE NEWSWIRE) -- The "Oncology Biomarkers: Global Markets" report has been added to ResearchAndMarkets.com's offering. The global oncology biomarkers market reached a...
USD 12.6 Bn Cancer Biomarkers Market to Grow at a CAGR of 9.9% During 2022 to 2031 - Global Analysis by Transparency Market Research
26 avr. 2023 06h30 HE
|
Transparency Market Research
Wilmington, Delaware, United States, April 26, 2023 (GLOBE NEWSWIRE) -- According to Transparency Market Research, tThe global cancer biomarkers market size stood at USD 12.6 Bn in 2021. The market...
Thyroid Cancer Market to Grow at a Substantial Growth Rate, Predicts DelveInsight | Novartis, AffyImmune Therapeutics, Eli Lilly, Loxo Oncology, Bristol-Myers Squibb, and Others Expected to Propel Market
12 avr. 2023 13h00 HE
|
DelveInsight Business Research LLP
New York, USA, April 12, 2023 (GLOBE NEWSWIRE) -- Thyroid Cancer Market to Grow at a Substantial Growth Rate, Predicts DelveInsight | Novartis, AffyImmune Therapeutics, Eli Lilly, Loxo Oncology,...
Novartis AG, AstraZeneca Plc, and Pfizer Inc Among Leading Companies in the Thyroid Cancer Pipeline Products Market | Globaldata Plc
05 juil. 2022 06h00 HE
|
GlobalData Plc
LONDON, July 05, 2022 (GLOBE NEWSWIRE) -- The “Thyroid Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update” report offered by GlobalData Plc provides...
Thyroid Cancer Pipeline Offers Promising New Options for Treatment | DelveInsight
02 mai 2022 13h00 HE
|
DelveInsight Business Research LLP
New York, USA, May 02, 2022 (GLOBE NEWSWIRE) -- Thyroid Cancer Pipeline Offers Promising New Options for Treatment | DelveInsight Thyroid Cancer Pipeline involves 40+ key companies continuously...
Tyrokinse Kinase Inhibitors in the Global Oncology Market 2021: Market Leaders by Indication and Product
05 nov. 2021 05h58 HE
|
Research and Markets
Dublin, Nov. 05, 2021 (GLOBE NEWSWIRE) -- The "Oncology Markets for Tyrokinse Kinase Inhibitors" report has been added to ResearchAndMarkets.com's offering. Traditional cancer therapy has focused...
Global Cancer Biopsy Market Analysis Report 2021: Advent of Liquid Biopsy & Transition of Novel Oncology Diagnostics from Bench to Clinics - Forecast to 2027
20 sept. 2021 04h43 HE
|
Research and Markets
Dublin, Sept. 20, 2021 (GLOBE NEWSWIRE) -- The "Global Cancer Biopsy Market Size, Share & Trends Analysis Report 2021-2027" report has been added to ResearchAndMarkets.com's offering. The global...
Interpace Biosciences Announces Another Pricing improvement for its Thyroid Assay
11 févr. 2020 06h55 HE
|
Interpace Biosciences, Inc.
Parsippany, NJ, Feb. 11, 2020 (GLOBE NEWSWIRE) -- Interpace Biosciences, Inc. (Nasdaq: IDXG) today announced that the Center for Medicare and Medicaid Services (CMS) has modified the reimbursement...
Interpace Biosciences Announces New Draft LCD and Reimbursement for Its Proprietary Thyroid Assay, ThyGeNEXT®
17 déc. 2019 06h55 HE
|
Interpace Biosciences, Inc.
Parsippany, NJ, Dec. 17, 2019 (GLOBE NEWSWIRE) -- Interpace Biosciences, Inc. (Nasdaq: IDXG) today announced that its Medicare Administrative Contractor (MAC) has issued a new draft local coverage...
Interpace Diagnostics Enters Agreement with Predictive Oncology to Enhance Diagnosis of Thyroid Cancer Via AI-Driven Analysis
18 juil. 2019 06h55 HE
|
Interpace Diagnostics Group, Inc.
PARSIPPANY, NJ, July 18, 2019 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group, Inc. (NASDAQ: IDXG) (“Interpace” or the “Company), announced today that it has executed an agreement with the Helomics...